STREPTASE
STREPTASE
Discontinued
DIN Number
02018993
Drug Class
Human
Market Date
Dec 31, 1994
Company
HC
csl behring canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02018993
AIG Number0107605001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B01AD01 STREPTOKINASE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntracoronary
,
Intravenous
AHFS Classification20:12.20
Health Canada Classification
ACTIVE INGREDIENTS (1)
STREPTOKINASEActive
Strength: 250000 UNIT / VIAL
Monograph: STREPTOKINASE